Abeona Therapeutics's market cap is currently $280.49M. The company's EPS TTM is $1.71; its P/E ratio is 8.67; Abeona Therapeutics is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
